找化学品上960化工网!
960化工网

地伐西匹 | 103420-77-5

地伐西匹结构式图片|103420-77-5结构式图片
地伐西匹
Devazepide
103420-77-5
C25H20N4O2
408.4519
如需查看该化合物的详细结构式,mol文件,smile,InChi 请点击:地伐西匹结构式
329798778
地伐西匹价格
简介
Devazepide (L-364,718) 是一种有效、竞争性、选择性、可口服的非肽类胆囊收缩素受体 (cholecystokinin (CCK) receptor) 拮抗剂,对大鼠胰腺、牛胆囊和豚鼠大脑 CCK 受体的 IC50 值分别为 81 pM,45 pM 和 245 nM。Devazepide (L-364,718) 对肠胃疾病有效。
名称和标识符
MDL MFCD00864500
InChIKey NFHRQQKPEBFUJK-HSZRJFAPSA-N
Inchi InChI=1S/C25H20N4O2/c1-29-21-14-8-6-12-18(21)22(16-9-3-2-4-10-16)27-23(25(29)31)28-24(30)20-15-17-11-5-7-13-19(17)26-20/h2-15,23,26H,1H3,(H,28,30)
SMILES CN1C2C=CC=CC=2C(C2C=CC=CC=2)=NC(NC(C2=CC3C(=CC=CC=3)N2)=O)C1=O
别名信息
- 中文别名 -
  • 地伐西匹
- 英文别名 -
  • 1H-Indole-2-carboxamide,N-[(3S)-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-
  • Devazepide
  • N-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-1H-indole-2-carboxamide
  • Devazepida
  • Devazepidum
  • MK-329
  • (S)-N-(2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)indole-2-carboxamide
  • MK 329
  • L-364718
  • EVAZEPIDE, PANOS
  • (3S)-1-Methyl-3-[(1H-indol-2-yl)carbonylamino]-5-phenyl-1H-1,4-benzodiazepin-2(3H)-one
  • N-[(3S)-2,3-DIHYDRO-1-METHYL-2-OXO-5-PHENYL-1H-1,4-BENZODIAZEPIN-3-YL]-1H-INDOLE-2-CARBOXAMIDE
  • L-364,718
  • DEVAZEPIDE
  • DTXCID0026092
  • HMS3268J20
  • J-000963
  • 1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide(Devazepide or (R) L364718)
  • N-[(3S)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-1H-indole-2-carboxamide
  • N-[(3S)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]-1H-indole-2-carboxamide
  • NFHRQQKPEBFUJK-HSZRJFAPSA-N
  • DEVAZEPIDE [INN]
  • 1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide
  • Tox21_111744_1
  • NS00123725
  • CCK antagonist synthetic 17
  • NSC778303
  • 103420-77-5
  • Devazepida [INN-Spanish]
  • HY-106301
  • MS-27018
  • JE6P7QY7NH
  • Q5266620
  • Devazepide (USAN/INN)
  • CAS-103420-77-5
  • 3(S)-(-)-1,3-Dihydro-3-(2-indolecarbonylamino)-1-methyl-5-phenyl-2H-(1,4)benzodiazepin-2-one
  • NCGC00159551-01
  • 1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide (MK-329, L-364,718)
  • 1H-Indole-2-carboxylic acid ((S)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide
  • BRN 5156082
  • PDSP2_000922
  • (S,Z)-N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-1H-indole-2-carboxamide
  • SCHEMBL148766
  • 1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide(devazepide)
  • CHEMBL9506
  • NSC-778303
  • 1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide: 0.1C4H10O. 0.15CH2Cl2
  • DTXSID2046092
  • 1H-Indole-2-carboxamide, N-(2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-, (S)-
  • AKOS024457038
  • UNII-JE6P7QY7NH
  • 1H-Indole-2-carboxamide, N-[(3S)-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-
  • 1H-Indole-2-carboxamide, N-[(3S)-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-
  • CHEBI:4460
  • Devazepide [USAN:INN]
  • D02693
  • Devacade
  • BRD-K31238592-001-01-6
  • L 364,718
  • 1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide(L-364718)
  • Devazepidum [INN-Latin]
  • (R)-1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide: 0.1C4H10O
  • (S)-1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide
  • (S)-N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-1H-indole-2-carboxamide
  • Tox21_111744
  • Devazepide, >=98% (HPLC), powder
  • BDBM50005463
  • NCGC00159551-02
  • PDSP1_000936
  • 1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide (L-364,718 ((S)-devazepide)
  • CS-0025544
  • MFCD00864500
  • (Z)-N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-1H-indole-2-carboxamide
  • DEVAZEPIDE [USAN]
  • L 364718
  • CCK antagonist synthetic 18
物化性质
实验特性
LogP 3.62930
PSA 77.56000
折射率 1.696
沸点 758.6°Cat760mmHg
闪点 412.6°C
溶解度 DMSO: >5mg/mL
密度 1.31
计算特性
精确分子量 408.15900
氢键供体数量 2
氢键受体数量 3
可旋转化学键数量 3
同位素质量 408.159
重原子数量 31
复杂度 716
同位素原子数量 0
确定原子立构中心数量 1
不确定原子立构中心数量 0
确定化学键立构中心数量 0
不确定化学键立构中心数量 0
共价键单元数量 1
疏水参数计算参考值(XlogP) 4.2
拓扑分子极性表面积 77.6A^2
相关文献
专业数据库参考
PubChemId 329798778
960化工网为您提供地伐西匹专业化合物百科信息,包括中文名,英文名,分子式,分子量,以及该化合物的CasNo.:103420-77-5,和相关理化性质;并提供了优质生产厂家信息包括厂家名称和联系方式等;| WAP 版:103420-77-5
平台客服 平台客服

平台在线客服